General Information

Speakers of ISM 2022

Introduction of Targeting Microbiota 2022

On behalf of the International Society of Microbiota, we are pleased to inform you that its 9th Annual World Meeting on Targeting Microbiota will be held on October 19-21, 2022, in Paris, France and online. 

During Targeting Microbiota 2022, we will discuss the following topics:

• Microbiota & Microbiota Dysbiosis in Diseases: Recent Advances
• Nutrition, Water and Microbiota: The Missing Links
• Immunotherapy, Antibiotic Resistance, Cancer & Microbiota: Towards Personalized Medicine
• Strategies, Innovations & Challenges to Target Microbiota Dysbiosis

Among the other hot topics that will be covered: Oral microbiota, vaginal microbiota, microbiota biofilms, retinal disorders, respiratory infections, arterial thrombosis, ischemic stroke, ageing, circadian system, depression, FMT, multi-omics, gene editing, precision medicine, cancer immunotherapy, mineral water, Mediterranean diet, weight loss.

The workshop on Gut Microbiota will be held on the first day, October 19, by Dr. Carole Nicco. The workshop will be online recorded, and Dr. Nicco will answer to all your questions live at the end of the workshop.

I do believe that this would be the best future strategy for the 9th World Congress of Targeting Microbiota in 2022: a strong communication between basic, pre-clinical scientists and clinicians.

So, I hope to meet you this October to capture moments of conviviality and scientific inspiration by the many and best scientists we have in the world studying the various aspects of the microbiota.

All our warmest regards.

Prof. Peter C. Konturek

Teaching Hospital of the University of Jena, Germany
President of the International Society of Microbiota
www.microbiota-site.com

Speakers of ISM 2022

FMT 2022: Reorganization and Perspective  Peter C. Konturek, President of ISM from the Teaching Hospital of the University of Jena, Germany

Microbiota & Microbiotal Medicine: Where We are Now & What’s Next? Marvin Edeas, Founder & Chairman of ISM, Institut Cochin, INSERM, Université de Paris, France

Microbiota and Drug Metabolism: Towards a Personalized Medicine Cristina Giaroni, University of Insubria, Italy

Role of the Gut Microbiota in Arterial Thrombosis Christoph Reinhardt, University Mainz, Germany

May the Microbiota of the Long-Lived Naked Mole-Rat Affect Human Health? Gerd Birkenmeier, University of Leipzig, Germany

Understanding the Heterogeneity of Host-associated Microbial Communities Lei Dai, Shenzhen Institutes of Advanced Technology, China

Gut Microbiota-Derived Extracellular Vesicles on Obesity, Diabetes and Metabolism Fermin I. Milagro, University of Navarra, Spain

Microbial and Nutritional Influence on Endocrine Control of Growth François Leulier, Université de Lyon, France

Precision Nutrition to Modulate Gut Microbiota in Reproductive Health and Pregnancy Annalisa Terranegra, Sidra Medical and Research Center, Qatar

Exploring a Healthy Human Gut Microbiota in a Mediterranean Cohort Andrés Moya, University of València, Spain

Interpreting Microbiomes Via Multi-omics for Precision Health Nathan Price, Thorne HealthTech, USA

Beneficial Effects of Natural Mineral Waters on Intestinal Inflammation and the Mucosa-Associated Microbiota Nicolas Barnich, Université Clermont Auvergne, France

Manipulating Fiber Polysaccharide Structure to Alter Targeting to Gut Microbiota Stephen Lindemann, Purdue University, USA

Short-chain Fatty Acids as Modulators of Redox Signaling in Health and Disease Carmen González-Bosch, Universitat de València, Spain

Proof-of-Principle Demonstration of Endogenous Circadian System and Circadian Misalignment Effects on Human Oral Microbiota Frank Scheer, Harvard Medical School, USA

The Probiotic Strain H. alvei HA4597 for Weight Loss Pierre Déchelotte, Rouen Normandy University, France

Probiotics and FMT as Add-On Therapies for Depression André Schmidt, University of Basel, Switzerland

Oral Microbial Dysbiosis and Oral Diseases Xin Xu, Sichuan University, China

Microbial Biomarkers to Predict Respiratory Infection Claire A. Woodall, University of Bristol, United Kingdom

Host-Microbes Mechanisms during E. coli Infections and Diet-induced Dysmetabolism Matteo Serino, CRCN INSERM, France

Cancer Therapy and Microbiota Maria Cecilia Giron, University of Padova, Italy

Fecal Microbiota Transplantation as an Immunomodulatory and Anti-Infective Agent Jarosław Biliński, Medical University of Warsaw, Poland

Host / Microbiota Interaction at the Mucosal Surface – Importance of a No Man’s Land ! Benoit Chassaing, Institut Cochin, France

Interactions Between Epithelial Proteases And Gut Microbiota Biofilms During Intestinal Disease Jean-Paul Motta, Institute of Digestive Health Research, France

Influence of the Gut Microbiome in Ischemic Stroke Risk and Ischemic Stroke Outcome Miquel Lledós, Biomedical Research Institute Sant Pau, Spain

A Gut Commensal, Parabacteroides distasonis, and Type 1 Diabetes Onset Emrah Altindis, Biology Department Boston College, USA

Gene Editing and Microbiome Therapy Nahla Mansour, National Reseacrh Center, Egypt

Vaginal Microbiota and Dysbiosis: Recent Advances and Perspective Gary Ventolini, Texas Tech University Health Sciences Center, USA

Gut Microbiome and Retinal Disorders: Recent Advances and Perspectives Dimitra Skondra, University of Chicago, USA

Interactions of Skin Microbiota with Chosen Plant Extracts and Natural Products Sebastian Granica, Medical University of Warsaw, Poland

Happy Holidays from International Society of Microbiota